DUR-928 Rocks

$Durect (DRRX.US)$ I agree very much with DRRX being under the radar! Currently only about 40% of shares are owned by institutions. Big Money IMO will come in after DUR-926 trial results are made public by the end of the year and DRRX share price will then Rock! On a more serious note what I like about DRRX is not only it's potential to reward shareholders but also Durect's ability to save the countless lives of AH patients. There is no effective treatment for the 150,000 plus AH patients hospitalized yearly in the USA and the hundred of thousands of AH patients in the EU and other nations. IMO after FDA gives the final green light on NDA Durect becomes a prime target for acquisition by big Pharma.